Wanbury Limited (BSE: 524212)
Health Care · Pharmaceuticals · IN
Rs195.85
-1.58% today · -22.8% 1Y
Wanbury Limited (BSE: 524212) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $70.71M.
Over the last twelve months the share price has lost 22.8%, trading between 162.00 and 360.00.
Tweenvest scores Wanbury Limited across four factors: quality 64/100, value 52/100, growth 58/100. Its strongest factor is quality.
524212 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.71M
- Revenue (TTM)
- $69.03M
- P/E
- 11.99
- EPS
- 16.34
- Dividend yield
- —
- Beta (5Y)
- 0.18
- 52-week high
- Rs360.00
- 52-week low
- Rs162.00
- Avg volume (3M)
- —
- Shares outstanding
- 34.94M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Domesco Medical Import - Export Joint-Stock CorporationHOSE: DMC | $71.51M | ₫53,300.00 | -2.74% |
| Cingulate Inc.NasdaqCM: CING | $71.11M | $4.85 | -0.82% |
| Cantourage Group SEXTRA: HIGH | $70.93M | €4.98 | -1.97% |
| Bangkok Lab And Cosmetic Public Company LimitedSET: BLC | $70.81M | ฿3.96 | +0.51% |
| DongKoo Bio & Pharma Co., Ltd.KOSDAQ: A006620 | $70.70M | ₩3,515.00 | -0.14% |
| Verrica Pharmaceuticals Inc.NasdaqCM: VRCA | $70.60M | $4.08 | -0.73% |
| Poolbeg Pharma PLCAIM: POLB | $69.71M | £0.07 | -3.90% |
| KOREA PHARMA Co., Ltd.KOSDAQ: A032300 | $69.53M | ₩8,570.00 | -1.72% |
Figures last refreshed Oct 11, 2026.